Holly K. Huynh

Antimicrobial Resistance among Clinical Isolates of <i>Streptococcus pneumoniae</i> in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

Gary V. Doern, Kristopher P. Heilmann, Holly K. Huynh et al. · Antimicrobial Agents and Chemotherapy · 2001 · 540 citations · Full text

Antimicrobial Resistance with <i>Streptococcus pneumoniae</i> in the United States, 1997–98

Gary V. Doern, Angela B. Brueggemann, Holly K. Huynh et al. · Emerging infectious diseases · 1999 · 188 citations · Full text

Fluoroquinolone Resistance in <i>Streptococcus pneumoniae</i> in United States since 1994-1995

Angela B. Brueggemann, Stacy L. Coffman, Paul R. Rhomberg et al. · Antimicrobial Agents and Chemotherapy · 2002 · 141 citations · Full text

Antimicrobial Chemotherapy, Antibiotic Resistance, Bacterial Pathogens +20

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of <i>Candida</i> spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

Michael A. Pfaller, S. A. Messer, L. Boyken et al. · Antimicrobial Agents and Chemotherapy · 2002 · 129 citations · Full text

Activities of Doripenem (S-4661) against Drug-Resistant Clinical Pathogens

Ronald N. Jones, Holly K. Huynh, Douglas J. Biedenbach · Antimicrobial Agents and Chemotherapy · 2004 · 116 citations · Full text

Antimicrobial Chemotherapy, Doripenem Mics, Bacterial Pathogens +20